Risk factors and some aspects of pancreatic cancer prevention

Pancreatic cancer is a malignant tumor of the digestive system with a poor prognosis. Most patients suffering from pancreatic cancer are diagnosed only at a late stage due to its aggressiveness and lack of early symptoms. This limits treatment options and results in a low five-year survival rate of 3-15%. However, pancreatic cancer is relatively rare, so screening of asymptomatic adults is not currently considered viable. The main purpose of this review is to highlight the main development strategies of early pancreatic cancer screening. This review is an in-depth analysis of the main methods of identifying high-risk groups and the procedures of carrying out a detailed study in these cohorts.